In this question-and-answer discussion of "generic" biologics, the authors contend small changes in manufacturing of biologics dramatically affect the safety and efficacy of the therapeutic molecule.
Genesio Murano
Advertisement
Articles by Genesio Murano
Advertisement
Latest Updated Articles
Biologics: Can There Be Abbreviated Applications, Generics, or Follow-On Products?Published: July 1st 2003 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Orion and Abzena Collaboration Highlights Integrated Antibody Manufacturing Advances
2
SK pharmteco Invests in California Site to Overcome Peptide Purification Bottlenecks
3
Ask the Expert: Commenting on Draft Regulations
4
Challenges, Innovations, and Future Outlook of Biologics Formulations
5
